AB Science (EUR)
AB
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range16.36 | 17.10
52-Wk Range- | -
Last Close16.70
Mkt Cap (m)740.71
Dividend yield-
ISINFR0010557264
Volume270,539.00
Exchange VenuePAR

Company Profile

AB Science is a pharmaceutical company. It is engaged in research, development, & commercialization of tyrosine kinase inhibitors, therapeutic drugs used in treating cancerous tumors, inflammatory & neuro-degenerative diseases in both humans & animals.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales420.16
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.ab-science.com

Financials

Income Statement
EUR201520162017201820192020
Revenue (m)2.281.511.741.701.57-
Operating Income (m)-25.96-30.21-28.40-28.94-17.47-
Net Income (m)-26.72-27.70-27.12-26.06-21.75-
Basic EPS-0.78-0.78-0.75-0.69-0.55-
Avg. Diluted Shares Outstanding (m)34.2035.6535.9937.7839.40-
Balance Sheet
EUR201520162017201820192020
Current Assets (m)30.6036.1248.6420.7114.09-
Non Current Assets (m)1.971.891.961.783.66-
Total Assets (m)32.5838.0150.6022.4917.74-
Current Liabilities (m)17.6120.3418.7119.2019.53-
Total Liabilities (m)------
Total Equity (m)-17.26-4.7110.74-14.96-26.83-
Cash Flows
EUR201520162017201820192020
Operating Cash Flows (m)-23.16-33.52-22.90-26.79-15.16-
Capital Expenditure (m)-0.62-0.52-0.50-0.48-0.39-
Figures are quoted in EUR unless stated otherwise
0.10 (0.60%)
16.80
Last Price